Two Sigma Investments, LP I Mab Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

A detailed history of Two Sigma Investments, LP transactions in I Mab stock. As of the latest transaction made, Two Sigma Investments, LP holds 575,580 shares of IMAB stock, worth $909,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares

575,580

Previous 574,901 0.12%

Holding current value

$909,416

Previous $1.09 Million 2.01%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.54 - $2.37 $1,045 - $1,609	679 Added 0.12%	575,580 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$1.21 - $1.9 $133,311 - $209,332	110,175 Added 23.71%	574,901 $1.09 Million
Q3 2023 Nov 14, 2023	BUY	$1.18 - $3.06 $137,700 - $357,086	116,695 Added 33.53%	464,726 $613,000
Q2 2023 Aug 14, 2023	BUY	$2.95 - $3.85 $322,541 - $420,943	109,336 Added 45.81%	348,031 $1.04 Million
Q1 2023 May 15, 2023	SELL	$3.08 - $7.39 $541,565 - $1.3 Million	-175,833 Reduced 42.42%	238,695 $825,000

Q4 2022 Feb 14, 2023	SELL	$3.22 - $4.86 $190,144 - $286,987	-59,051 Reduced 12.47%	414,528 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$4.01 - $12.34 $1.71 Million - $5.25 Million	425,279 Added 880.49%	473,579 $1.9 Million
Q2 2022 Aug 15, 2022	SELL	$8.27 - $18.43 $4.03 Million - $8.98 Million	-487,296 Reduced 90.98%	48,300 $546,000
Q1 2022 May 16, 2022	BUY	$12.54 - $46.93 $5.23 Million - $19.6 Million	417,060 Added 351.84%	535,596 $8.7 Million
Q4 2021 Feb 14, 2022	BUY	$45.28 - $74.5 $5.03 Million - $8.28 Million	111,166 Added 1508.36%	118,536 $5.62 Million
Q3 2021 Nov 15, 2021	BUY	$57.18 - $84.43 $421,416 - $622,249	7,370 New	7,370 $534,000
Q1 2021 May 17, 2021	SELL	$44.38 - $63.97 $1.05 Million - $1.51 Million	-23,618 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$32.94 - $47.15 $777,976 - $1.11 Million	23,618 New	23,618 $1.11 Million

Others Institutions Holding IMAB

# of Institutions

Shares Held

16M

Call Options Held

11.9K

Put Options Held

3.5K

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $131M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP I Mab Transaction History